{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:51:02Z","timestamp":1791427862905,"version":"4.3.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,7]]},"DOI":"10.7759\/cureus.117612","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:25:21Z","timestamp":1791426321000},"source":"Crossref","is-referenced-by-count":0,"title":["Cerebellar Metastasis From Radioiodine-Refractory Widely Invasive Oncocytic (Hurthle Cell) Carcinoma of the Thyroid in a Young Adult"],"prefix":"10.7759","author":[{"given":"Meera","family":"Davuluri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maansi","family":"Bhasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch ZW","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, et al.. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022, 33:27-63. 10.1007\/s12022-022-09707-3","journal-title":"Endocr Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma","volume":"34","author":"Gopal RK","year":"2018","unstructured":"Gopal RK, K\u00fcbler K, Calvo SE, et al.. Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in H\u00fcrthle cell carcinoma. Cancer Cell. 2018, 34:242-55.e5. 10.1016\/j.ccell.2018.06.013","journal-title":"Cancer Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.07.002","article-title":"Integrated genomic analysis of H\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes","volume":"34","author":"Ganly I","year":"2018","unstructured":"Ganly I, Makarov V, Deraje S, et al.. Integrated genomic analysis of H\u00fcrthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes. Cancer Cell. 2018, 34:256-70.e5. 10.1016\/j.ccell.2018.07.002","journal-title":"Cancer Cell"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.11.4386","article-title":"Prognosis and treatment of brain metastases in thyroid carcinoma","volume":"82","author":"Chiu AC","year":"1997","unstructured":"Chiu AC, Delpassand ES, Sherman SI. Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab. 1997, 82:3637-42. 10.1210\/jcem.82.11.4386","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00241","article-title":"Brain metastases from differentiated thyroid carcinoma: prevalence, current therapies, and outcomes","volume":"3","author":"Gomes-Lima CJ","year":"2019","unstructured":"Gomes-Lima CJ, Wu D, Rao SN, et al.. Brain metastases from differentiated thyroid carcinoma: prevalence, current therapies, and outcomes. J Endocr Soc. 2019, 3:359-71. 10.1210\/js.2018-00241","journal-title":"J Endocr Soc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee","volume":"14","author":"Tessler FN","year":"2017","unstructured":"Tessler FN, Middleton WD, Grant EG, et al.. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017, 14:587-95. 10.1016\/j.jacr.2017.01.046","journal-title":"J Am Coll Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda System for Reporting Thyroid Cytopathology","volume":"27","author":"Cibas ES","year":"2017","unstructured":"Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017, 27:1341-6. 10.1089\/thy.2017.0500","journal-title":"Thyroid"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0102","article-title":"Updated American Joint Committee on Cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why?","volume":"27","author":"Tuttle RM","year":"2017","unstructured":"Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why?. Thyroid. 2017, 27:751-6. 10.1089\/thy.2017.0102","journal-title":"Thyroid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0246","article-title":"Radioactive iodine treatment is associated with improved survival for patients with H\u00fcrthle cell carcinoma","volume":"26","author":"Jillard CL","year":"2016","unstructured":"Jillard CL, Youngwirth L, Scheri RP, Roman S, Sosa JA. Radioactive iodine treatment is associated with improved survival for patients with H\u00fcrthle cell carcinoma. Thyroid. 2016, 26:959-64. 10.1089\/thy.2016.0246","journal-title":"Thyroid"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante C","year":"2006","unstructured":"Durante C, Haddy N, Baudin E, et al.. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006, 91:2892-9. 10.1210\/jc.2005-2838","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen BR","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al.. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016, 26:1-133. 10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.7.5827","article-title":"[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels","volume":"84","author":"Wang W","year":"1999","unstructured":"Wang W, Macapinlac H, Larson SM, et al.. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab. 1999, 84:2291-302. 10.1210\/jcem.84.7.5827","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger M","year":"2015","unstructured":"Schlumberger M, Tahara M, Wirth LJ, et al.. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015, 372:621-30. 10.1056\/NEJMoa1406470","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3801002","article-title":"Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms","volume":"21","author":"Nonaka D","year":"2008","unstructured":"Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol. 2008, 21:192-200. 10.1038\/modpathol.3801002","journal-title":"Mod Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/536197-cerebellar-metastasis-from-radioiodine-refractory-widely-invasive-oncocytic-hurthle-cell-carcinoma-of-the-thyroid-in-a-young-adult","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:25:28Z","timestamp":1791426328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/536197-cerebellar-metastasis-from-radioiodine-refractory-widely-invasive-oncocytic-hurthle-cell-carcinoma-of-the-thyroid-in-a-young-adult"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.117612","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}